Ruslan R Rafikov

Title: Innovations of Ruslan R Rafikov

Introduction

Ruslan R Rafikov is a notable inventor based in Evans, GA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic peptides. With a total of 2 patents, his work focuses on addressing critical health issues related to tissue damage.

Latest Patents

Rafikov's latest patents include innovative short peptides that are useful for the treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species. These inventions disclose isolated short peptides comprising the amino acid sequence Cys-Glu-Phe-His (CEFH; SEQ ID NOS: 1 and 15) and their analogs. The CEFH peptides are effective in mediating the denitration of 3-nitrotyrosines (3-NT) in cellular proteins, thereby preventing tissue damage associated with excess nitric oxide (NO) and its reactive species. These peptides are particularly useful in treating ischemia/reperfusion (I/R) injury of various tissues, including heart muscle, brain tissue, and liver tissue, among others.

Career Highlights

Rafikov is affiliated with New York University, where he continues to advance his research and innovations. His work has the potential to impact a wide range of medical conditions, including neurodegenerative diseases, septic shock, and various inflammatory disorders.

Collaborations

Rafikov collaborates with Evgeny A Nudler, enhancing the scope and impact of their research endeavors.

Conclusion

Ruslan R Rafikov's contributions to the field of biomedical research through his innovative peptides demonstrate his commitment to addressing significant health challenges. His work continues to pave the way for advancements in medical treatments.